duloxetine hydrochloride has been researched along with Breast Cancer in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 8 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Crew, KD; Fisch, MJ; Henry, NL; Hershman, DL; Till, C; Unger, JM | 1 |
| Asano, H; Hiramoto, S; Kawabata, A; Miyamoto, T; Takegami, M | 1 |
| Aghabozorgi, R; Babaee, M; Hashemi, M; Hesam, M; Rayegani, SM; Zahed, G | 1 |
| Alipour, A; Avan, R; Hendouei, N; Janbabaei, G; Salehifar, E; Tabrizi, N | 1 |
| Elgalaly, NA; Fattah Mohammad, MA; Hetta, DF; Hetta, HF | 1 |
| Bartlett, E; Kaye, AD; Urits, I; Urman, RD; Viswanath, O | 1 |
| Henry, NL; Lustberg, MB; Schnell, PM | 1 |
| Cortopassi, G; De Mario, A; Hill, JM; Ketteler, R; Kriston-Vizi, J; Mammucari, C; Rizzuto, R; Szabadkai, G; Tosatto, A; Vecellio Reane, D | 1 |
| Burton, GV; Fehrenbacher, L; Fisch, MJ; Flynn, PJ; Henry, NL; Hershman, DL; Kuzma, CS; Lew, DL; Moinpour, CM; Moseley, A; Prow, DM; Schott, AF; Sharer, CW; Unger, JM; Wade, JL | 1 |
| Marchant, J | 1 |
| Rocque, G | 1 |
| Bae, K; Jang, CE; Jung, MS; Kim, JR; Kim, M; Lee, JS; Sohn, EH; Yoo, HS | 1 |
| Ichiba, Y; Kajiume, S; Kiba, T; Morii, N; Mura, T; Nagashima, S; Ogawa, Y; Okada, Y; Takahashi, H; Yamashiro, H | 1 |
| Biglia, N; Bounous, VE; Pecchio, S; Sgro, LG; Susini, T; Torta, R; Tuninetti, V | 1 |
| Tanday, S | 1 |
7 trial(s) available for duloxetine hydrochloride and Breast Cancer
| Article | Year |
|---|---|
Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial.
Topics: Breast Neoplasms; Duloxetine Hydrochloride; Female; Humans; Neurotoxicity Syndromes; Paclitaxel; Peripheral Nervous System Diseases | 2023 |
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
Topics: Adult; Analgesics; Breast Neoplasms; Bridged-Ring Compounds; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Neuralgia; Pregabalin; Surveys and Questionnaires; Taxoids; Treatment Outcome | 2020 |
Preoperative Duloxetine to improve acute pain and quality of recovery in patients undergoing modified radical mastectomy: A dose-ranging randomized controlled trial.
Topics: Acute Pain; Analgesics, Opioid; Breast Neoplasms; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Mastectomy; Mastectomy, Modified Radical; Pain Measurement; Pain, Postoperative | 2020 |
Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Confidence Intervals; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Patient Reported Outcome Measures; Placebos; Quality of Life | 2021 |
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Neoplasm Staging; Pain Measurement; Time Factors; Treatment Outcome; United States | 2018 |
The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
Topics: Activities of Daily Living; Analgesics; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Duloxetine Hydrochloride; Electric Stimulation Therapy; Female; Humans; Peripheral Nervous System Diseases; Pregabalin; Quality of Life; Randomized Controlled Trials as Topic; Republic of Korea; Time Factors; Treatment Outcome | 2018 |
Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cancer Survivors; Citalopram; Depressive Disorder, Major; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Hot Flashes; Humans; Medication Adherence; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Tablets; Treatment Outcome | 2018 |
8 other study(ies) available for duloxetine hydrochloride and Breast Cancer
| Article | Year |
|---|---|
Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
Topics: Acupuncture Analgesia; Adult; Aged; Aged, 80 and over; Analgesics; Aromatase Inhibitors; Breast Neoplasms; Duloxetine Hydrochloride; Fatty Acids, Omega-3; Female; Humans; Logistic Models; Middle Aged; Musculoskeletal Pain; Pain Management; Pain Measurement; Patient Reported Outcome Measures; Randomized Controlled Trials as Topic | 2021 |
Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Cancer Survivors; Drug Therapy; Duloxetine Hydrochloride; Female; Genital Neoplasms, Female; Humans; Japan; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Risk Factors | 2021 |
What is the optimal preoperative dose of duloxetine to reduce acute pain in patients undergoing modified radical mastectomy?
Topics: Acute Pain; Breast Neoplasms; Duloxetine Hydrochloride; Female; Humans; Mastectomy; Mastectomy, Modified Radical; Pain, Postoperative | 2022 |
Identification and functional validation of FDA-approved positive and negative modulators of the mitochondrial calcium uniporter.
Topics: Animals; Apoptosis; Benzethonium; Breast Neoplasms; Calcium; Calcium Channels; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytoprotection; Duloxetine Hydrochloride; Energy Metabolism; Female; High-Throughput Screening Assays; Homeostasis; Humans; Hypertrophy; Mice; Mitochondria; Morpholines; Muscle Fibers, Skeletal; Muscle, Skeletal; Oxygen Consumption; Reactive Oxygen Species; Reproducibility of Results; United States; United States Food and Drug Administration | 2021 |
Acupuncture in cancer study reignites debate about controversial technique.
Topics: Acupuncture; Antidepressive Agents; Aromatase Inhibitors; Breast Neoplasms; Cancer Pain; Duloxetine Hydrochloride; Female; Humans; Medication Adherence; Placebo Effect; Reproducibility of Results | 2017 |
What Is the Role of Symptom Management and Patient-Reported Outcomes in Adherence to Aromatase Inhibitors?
Topics: Aromatase; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Duloxetine Hydrochloride; Humans; Patient Reported Outcome Measures | 2018 |
[A case of Paclitaxel-induced peripheral neuropathy successfully treated with duloxetine].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Thiophenes; Trastuzumab | 2015 |
Duloxetine lessens joint pain in early-stage breast cancer.
Topics: Analgesics; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Duloxetine Hydrochloride; Female; Humans; Pain Measurement; Randomized Controlled Trials as Topic; Serotonin and Noradrenaline Reuptake Inhibitors; Time Factors; Treatment Outcome | 2017 |